Form D · Other Investment Fund
Revelis BioEclipse SPV IV LLC, a Series of Revelis SPV Master, LLC
Boulder, CO · CIK 0001821919
Offering snapshot reported Nov 10, 2020 · SEC filing
- Reported sold
- $490K Offering amount: $490K
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 9, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2020 | Initial | $490,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06c, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-380131
Source: Form D, filed Nov 10, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Llc Assure Fund Management Ii | Executive |
| Llc Revelis Capital Group, | Director |
| Richard Thoms | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
85 Huron Court
Boulder, CO, 80303
Boulder, CO, 80303